Cerebrospinal Fluid Management Market

Industry Overview

The Global Fertility Test Market is expected to grow from USD 0.59 billion in 2023 to USD 1.25 billion by 2030 at a compound annual growth rate (CAGR) of 7.63% during the forecast period ranging from 2025 to 2030.

Fertility test refers to the process of accessing fertility by doctors to check whether or not someone can have a baby naturally. Fertility testing is needed by those people who are above 35 years of age since age is an important factor that can affect the ability to have a baby. At this age, if someone has been trying for more than six months but is not having a baby might need fertility testing. These tests involve looking for hormones by doing some blood tests along with urine and saliva of women and semen of men to check the number of healthy sperm. The procedure is minimally invasive.

The global fertility test market is growing significantly due to the rise in the number of first-time pregnancy age and introduction of advanced fertility monitors with high-level accuracy. There are different products comprising the market out of which the ovulation predictor kits are expected to have a higher demand in the coming years. This is attributed to the minimal charge as compared to fertility monitors, higher efficiency, and low cost.

The high cost involved with the purchase of fertility testing monitors as well as the unproven precision of urine-based ovulation monitors are the significant challenges to the growth of the global fertility test market. Significant growth opportunities are offered to the market due to the rising infertility rates across the globe and its growing concern for couples wanting to seek help in identifying the causes of their fertility issues through these tests.

Market Segmentation

Insight by Product

The global fertility test market is divided by product into male fertility testing products, fertility monitors, and ovulation predictor kits. Out of them, the ovulation predictor kits segment will account for the larger share during the forecast period due to minimal charge, lower price, high efficiency, growing first-time pregnancy age, higher adoption, effortless OTC availability, and ease of use.

Insight by Mode of Purchase

The global fertility test market is divided by mode of purchase into prescription-based and non-prescription or OTC-based segments. The higher preference of patients towards self-monitoring and remote monitoring and ease of use and easy availability of fertility and ovulation monitors on e-commerce websites will facilitate the growth of the non-prescription or OTC-based fertility tests segment.

Insight by Application

The global fertility test market is divided by application into female fertility testing and male fertility testing. The decreasing female fertility rates, the high price of IVF procedures, and availability of a wide range of fertility testing options propel the growth of the female fertility testing application.

Insight by End User

The global fertility test market is divided by different end users into hospitals, fertility clinics, home care settings, and other segments. The declining fertility rates in men and women, the growing need for continuous monitoring of health conditions, and the rising preference and demand for home and remote monitoring help in the growth of home care settings.

Insight by Distribution Channel

The global fertility test market is also divided by different distribution channels into hospital pharmacies, retail pharmacy, and online pharmacy. Out of these three segments, the retail pharmacy segment is expected to account for a larger share during the forecast period due to the rising number of pharmacies and chains as well as the wider availability of medications in supermarkets and mass retail centers.

Global Cerebrospinal Fluid Management Market Report Coverage

Industry Dynamics

Industry Trends

The growing acceptance of ovulation monitors based on basal body temperature and the effortless accessibility of monitors on e-commerce sites are notable trends in the fertility test market. In addition, there is also a significant development and release of advanced and user-friendly fertility monitors that offer higher accuracy noticed in the market.

Growth Drivers

The growth of the global fertility test market is attributed to different factors such as deteriorating fertility rates and the rapid technological advancement in fertility testing kits. It is also attributed to the growing awareness about fertility testing as well as the availability of more innovative kits such as the conjoined kits for double testing of pregnancy and ovulation. The high price associated with IVF testing as well as its lower accuracy also propels the growth of the fertility test market. In addition, changing lifestyles and unhealthy lifestyle choices such as smoking, poor diet, and excessive consumption of alcohol, along with several environmental factors such as exposure to pollutants also affect fertility and reproductive health, driving the need for fertility testing. In addition, the development of more effective Assisted Reproductive Technologies (ART) such as egg freezing, intracytoplasmic sperm injection (ICSI), and others have also increased the demand for fertility testing.

Challenges

One of the most significant challenges faced by the global fertility test market which impedes the market growth is the lower precision of ovulation prediction kits. In addition, new players across the world face stringent regulatory standards to enter the fertility test market, which prevents them from such endeavors. The high capital requirement aggravates the challenges and poses a significant entry barrier. Lack of awareness about fertility tests in rural areas also hinders market growth.

Opportunities

Developing countries like China and India offer new growth avenues to the market due to the growing prevalence of PCOS and obesity, increase in fertility education, and easy accessibility of fertility monitors through pharmacies, e-commerce websites, and retail shops/drugstores, and the growing demand for fertility and ovulation monitors. The introduction of flexible policies and integration of innovative technology into existing fertility testing protocols also offer novel growth prospects to the market.

Geographic Overview

North America is the largest contributor to the fertility test market due to higher usage of fertility monitoring devices for contraception, growing first-time pregnancy age, rising awareness about the benefits of ovulation monitors through social media, e-commerce sites, and marketing campaigns, and increase in the number of polycystic ovary syndrome.

The Asia-Pacific market will grow at a high rate during the forecast period due to the growing occurrence of lifestyle disorders, higher funding for the improvement of fertility and ovulation monitors, and the large number of manufacturers and suppliers of fertility testing.

Competitive Insight

Key players in the cerebrospinal fluid management market are catering to the demand for these devices by investing in technologically advanced products in their product portfolio across the globe. In May 2016, Medtronic PLC, received FDA clearance for StrataMR valves and shunts, for treatment of patients with hydrocephalus and cerebrospinal fluid disorders.

Medtronic PLC, Spiegelberg GmbH & Co. Kg, Deltasurgical, Integra Lifesciences Holdings Corporation, Natus Medical Incorporated, G.SURGIWEAR LTD, B. Braun Melsungen, Dispomedica GmbH, SOPHYSA, Moller Medical GmbH, and Wellong Instruments Co., Ltd are the key players offering cerebrospinal fluid management.

Spiegelberg GmbH & Co. KG from Hamburg specializes in the production and worldwide distribution of high-quality neurosurgical products. The German market and the close cooperation with experts are of particular importance. Spiegelberg offers a product portfolio that meets the high demands of medical technology, due to the scientific exchange with specialists in neurosurgery.

Delta Surgical Limited is a UK-based company that specializes in Medical Device Technology in Surgical and Critical Care. Delta is a privately owned company led by a team with many years of experience in providing excellent service to both NHS and private hospitals.

Recent Developments by Key Players

Integra LifeSciences Holdings Corporation (a global leader in medical technology) has agreed to acquire Acclarent Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company for USD 275 million in cash at closing, subject to customary purchase price adjustments and an additional USD 5 million upon the achievement of certain regulatory milestones. 

B. Braun Medical Inc. (B. Braun) is a leader in smart infusion therapy and pain management has launched its new CARESITE Micro Luer Access Device designed to reduce exposure to harmful chemicals and decrease infection risk, making IV access safer for patients and healthcare providers.

The Cerebrospinal Fluid Management Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Product
  • External drainage systems
  • Shunts
• By End User
  • Ventriculoperitoneal (VP) shunts
  • Lumboperitoneal (LP) shunts
  • Ventriculoatrial (VA) shunts
  • Ventriculopleural (VPL) shunts

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research